Visalytics
Visalytics
approved EB-2 (NIW)

Clinical R&D Analytics Manager

Clinical Data Analytics · Iran · 2025-01-29

Processing Time
60 days
Decision Date
2025-01-29
Location
South Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to integrate artificial intelligence and advanced data science methodologies into clinical research to reshape drug development and clinical trial design. His work focuses on using AI models to automate clinical trial protocols, uncovering healthcare disparities through data science, and developing predictive tools for diagnostic accuracy. The goal is to reduce the high costs of drug development and improve patient outcomes in the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the resource-intensive nature of drug development and healthcare disparities, which are national priorities.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, citation count, and extensive peer review experience demonstrate his capability to lead in this field.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's unique blend of AI innovation and practical healthcare application provides a benefit to the U.S. that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 2 peer-reviewed journal articles, 4 abstracts, and 5 preprints, which garnered 43 citations from independent scholars. His professional standing was further evidenced by completing at least 26 peer reviews for respected journals. The case successfully satisfied all three prongs of the Dhanasar framework, demonstrating the national importance of AI-driven healthcare solutions.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Judging Experience
Original Contributions

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Georgia 67 days 2025-05-14
The petitioner proposes to develop advanced artificial intelligence models and algorithms to improve early disease diagnosis and predict patient responses to new drugs and combination therapies. This work focuses on enhancing diagnostic precision and treatment effectiveness to accelerate drug discovery and optimize healthcare outcomes. The endeavor specifically aims to benefit vulnerable populations, including infants and the elderly, through optimized medical interventions.
View Case

Machine Learning Engineer

Artificial Intelligence · China

WeGreened EB-2 (NIW) rfe approved
145 days 2025-10-31
The petitioner proposes to continue developing advanced AI models for medical information extraction and drug dosage prediction. This work focuses on automating clinical data analysis and enhancing personalized medicine through causal relation extraction and drug interaction prediction. The intended impact is to improve clinical efficiency, patient safety, and healthcare decision-making within the U.S. healthcare system.
View Case

Data Engineer

Artificial Intelligence · Pakistan

WeGreened EB-2 (NIW) approved
Illinois 20 days 2024-09-05
The petitioner proposes to continue his work as a data engineer focusing on the convergence of data processing analytics and artificial intelligence. His research involves developing generative AI systems, multimodal large language models, and neurotechnologies to improve healthcare data integration and disease diagnosis. The work specifically aims to enhance diagnostic accuracy and personalized treatment strategies for neurological and cardiovascular diseases.
View Case

Consultant

Engineering · India

WeGreened EB-2 (NIW) approved
New Jersey 45 days 2025-01-16
The petitioner proposes to continue research on developing advanced machine learning, artificial intelligence, and language modeling frameworks by integrating data-driven methods with domain knowledge. This work aims to address key challenges in drug development and healthcare, specifically focusing on accelerating drug discovery, optimizing clinical trials, and enhancing manufacturing efficiency.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-29.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 60 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist